ISIN | LU1240803715 |
---|---|
Valor Number | 28368725 |
Bloomberg Global ID | UBXYEQD LX |
Fund Name | UBS (Lux) Strategy Xtra SICAV - Yield (EUR) Q-dist |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Asset Allocation |
EFC Category | Multi-Asset Global Advanced Markets Defensive |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment policy seeks to achieve an attractive level of earnings in terms of the currency of account, while assuming a moderate degree of risk. To this end, investments will be made on a broadly diversified basis throughout the world, primarily in bonds and equities. Up to 30% may be invested in alternative investments. In line with this investment policy, the sub-funds may invest in high-yield and emerging markets. |
Peculiarities |
Current Price * | 100.50 EUR | 16.04.2025 |
---|---|---|
Previous Price * | 100.56 EUR | 15.04.2025 |
52 Week High * | 104.41 EUR | 18.02.2025 |
52 Week Low * | 96.93 EUR | 19.04.2024 |
NAV * | 100.50 EUR | 16.04.2025 |
Issue Price * | 100.50 EUR | 16.04.2025 |
Redemption Price * | 100.50 EUR | 16.04.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 106,268,311 | |
Unit/Share Assets *** | 514,803 | |
Trading Information SIX |
YTD Performance | -0.87% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
---|---|---|
YTD Performance (in CHF) | -2.24% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
1 month | -2.53% |
17.03.2025 - 16.04.2025
17.03.2025 16.04.2025 |
3 months | -1.52% |
16.01.2025 - 16.04.2025
16.01.2025 16.04.2025 |
6 months | -1.83% |
16.10.2024 - 16.04.2025
16.10.2024 16.04.2025 |
1 year | +3.64% |
16.04.2024 - 16.04.2025
16.04.2024 16.04.2025 |
2 years | +7.96% |
17.04.2023 - 16.04.2025
17.04.2023 16.04.2025 |
3 years | +2.55% |
19.04.2022 - 16.04.2025
19.04.2022 16.04.2025 |
5 years | +14.26% |
16.04.2020 - 16.04.2025
16.04.2020 16.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Focused Hi Grd L/T Bd USD U-X-acc | 8.96% | |
---|---|---|
Star Compass PLC 0% | 8.44% | |
UBS (Lux) BS USDInvmGrdCorSust$Uxacc | 8.01% | |
Focused SICAV Hi Grd LT Bd EUR U-X-acc | 6.62% | |
UBS (Lux) BS € Corp Susts U-X-acc | 6.04% | |
UBS (Lux) EEF Glbl Bd $ U-X Acc | 4.84% | |
Focused SICAV High Grade Bd EUR U-X-acc | 4.44% | |
iShares MSCI USA Scrn ETF USD Acc | 4.30% | |
UBS (Lux) IF Key Sel Global Eq USD UXacc | 3.55% | |
UBS (Lux) ES Glb Opp sust($)U-XAcc | 3.43% | |
Last data update | 28.02.2025 |
TER | 1.12% |
---|---|
TER date | 31.10.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.76% |
Ongoing Charges *** | 1.10% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |